IOVAIovance Biotherapeutics, Inc.Running, no new patients
A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Melanoma
Melanoma (Skin Cancer) · Unresectable Melanoma · Metastatic Melanoma
0Calmworry score, out of 100
No strong warning signs right now. The score counts warning signs; it is not a prediction.
Why this score
No warning signs right now. That's why the score is 0.
Score over time
- Stage
- Phase 2
- Patients
- 24 (planned)
- Started
- Nov 28, 2025
- Main results expected
- Dec 2027
- Fully finished
- Jun 2028
- Results posted
- not yet
What counts as success
The trial's main goal(s), called the “primary outcome.”
Objective Response Rate
Measured over: 12 months
Changes Tremor has spotted
No changes since Tremor started watching this trial.
Show details (technical version)
Score inputs
- none
Raw record changes
- none yet
Trial ID NCT07288203 · record last updated 2026-10-01 · checked 2026-11-09 15:47 UTC